QUALITY CAREER DEVELOPMENT IN GLOBAL MEDICINES DEVELOPMENT

Track:
IMI Public-Private Partnership in Medicines Research Education and Training – for Professionals and for Patients

Day & Time:
March 6, 11:00AM - 12:30PM

Session Number:
1706

Room Number:
G104

Type:
Session

Title:
QUALITY CAREER DEVELOPMENT IN GLOBAL MEDICINES DEVELOPMENT

Chair(s):
Peter David Stonier, MD,PhD,FFPM,FRCP
Visiting Professor Pharmaceutical Medicine
King's College London, United Kingdom

Description:
Developing medicine from molecule to patient use is a process which was structured in post-graduate master programmes with detailed syllabus topics, translated into learning outcomes and competencies and bundled in 12 modules incl. two “elective” modules, offered on the PharmaTrain CPD Platform. Face-to-face learning is blended with (e)learning at master-level quality. There are additional training products e.g. Clinical Investigator Certification, CLIC as well as a new Master programme for Regulatory Affairs, MRA. The partnership of 23 European universities, 15 private EFPIA partners and another 13 professional societies and regulatory agencies is growing to a global platform with another 10 extra-European universities from UCSF to Peking University. A new global quality training in medicines development.

Presentation(s) & Speaker(s):
Global Personalised Modular Training Platform for Medicines Development and Regulation
Peter David Stonier, MD,PhD,FFPM,FRCP
Visiting Professor Pharmaceutical Medicine
King's College London, United Kingdom

The PharmaTrain Clinical Investigator Certification Initiative
Ingrid Klingmann, MD,PhD
Managing Director
Pharmaplex bvba, Belgium

The PharmaTrain Virtual Learning Platform
Detlef Niese, DrMed,RPh
Head, Development External Affairs
Novartis Pharma AG, Switzerland